Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 5K5E | P06276 | Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening | |
| 4RCH | P35557 | Discovery of 2-Pyridyl Ureas as Glucokinase Activators | |
| 4CZS | C0HJY1 | Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides | |
| 4CZS | 4CZS | Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides | |
| 6ZJZ | Q9NR97 | Discovery of M5049: a novel selective TLR7/8 inhibitor for treatment of autoimmunity | |
| 3PDF | P53634 | Discovery of Novel Cyanamide-Based Inhibitors of Cathepsin C | |
| 5KOQ | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | Renin (E.C.3.4.23.15) |
| 5KOS | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | Renin (E.C.3.4.23.15) |
| 5KOT | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | Renin (E.C.3.4.23.15) |
| 5BQH | O14684 | Discovery of a Potent and Selective mPGES-1 Inhibitor for the Treatment of Pain | |
| 5BQI | O14684 | Discovery of a Potent and Selective mPGES-1 Inhibitor for the Treatment of Pain | |
| 5NES | A0A069Q9V4 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
| 5NES | 5NES | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
| 5NEY | A0A069Q9V4 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
| 5NEY | 5NEY | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
| 5NF0 | A0A069Q9V4 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
| 5NF0 | 5NF0 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
| 5CSY | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - acarbose soak | |
| 5CSU | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - acarviostatin soak | |
| 5CPT | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - beta cyclodextrin soak | |
| 5CQ1 | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - cycloamylose soak | |
| 5CPS | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - maltotriose soak | |
| 7R10 | P0DTC2 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 | |
| 7R10 | Q9BYF1 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 | |
| 7R0Z | P0DTC2 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7R0Z | Q9BYF1 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7R11 | P0DTC2 | Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7R11 | Q9BYF1 | Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7R12 | P0DTC2 | Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7R12 | Q9BYF1 | Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7A91 | P0DTC2 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | Spike glycoprotein |
| 7A91 | Q9BYF1 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | Spike glycoprotein |
| 7A92 | P0DTC2 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) | Spike glycoprotein |
| 7A92 | Q9BYF1 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) | Spike glycoprotein |
| 6XR8 | P0DTC2 | Distinct conformational states of SARS-CoV-2 spike protein | Spike glycoprotein |
| 6XRA | P0DTC2 | Distinct conformational states of SARS-CoV-2 spike protein | Spike glycoprotein |
| 5L6N | P00734 | Disulfated madanin-thrombin complex | |
| 5L6N | Q86FP9 | Disulfated madanin-thrombin complex | |
| 3AZR | Q9X273 | Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Cellobiose | |
| 3AZT | Q9X273 | Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Cellotetraose | |
| 3AZS | Q9X273 | Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Mannotriose | |
| 6MSS | 6MSS | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | A11B8.2 NKT TCR alpha-chain, A11B8.2 NKT TCR beta-chain, Antigen-presenting glycoprotein CD1d1, Beta-2-microglobulin |
| 6MSS | P11609 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | A11B8.2 NKT TCR alpha-chain, A11B8.2 NKT TCR beta-chain, Antigen-presenting glycoprotein CD1d1, Beta-2-microglobulin |
| 6MSS | P01887 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | A11B8.2 NKT TCR alpha-chain, A11B8.2 NKT TCR beta-chain, Antigen-presenting glycoprotein CD1d1, Beta-2-microglobulin |
| 8JEM | Q5M4V4 | DltB tetramer in complex with inhibitor m-AMSA | |
| 4U3C | P9WQ16 | Docking Site of Maltohexaose in the Mtb GlgE | |
| 8F9O | A0A8C0LZX8 | Dog sialic acid esterase (SIAE) | |
| 8F9P | A0A8C0LZX8 | Dog sialic acid esterase (SIAE) inactive mutant S128A | |
| 7RFT | A0A2N0URA4 | Domain 1 of Starch adherence system protein 20 (Sas20) from Ruminococcus bromii with maltotriose | |
| 8GC2 | P42260 | Domoate-bound GluK2 kainate receptor in partially-open conformation 1 |
